Abandon hope for overhaul of India’s drug regulations
Today’s article in the Business Standard a good, albeit very harsh, summary of the debate over the regulation of clinical trials and drug manufacturing in India and gives a suggestion of the ways in which government wants to revise it. There are plans for a Drugs and Cosmetics Act 2013 to replace the colonial-era framework that …
Abandon hope for overhaul of India’s drug regulations Read More »
